Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8102189rdf:typepubmed:Citationlld:pubmed
pubmed-article:8102189lifeskim:mentionsumls-concept:C0079734lld:lifeskim
pubmed-article:8102189lifeskim:mentionsumls-concept:C0069515lld:lifeskim
pubmed-article:8102189lifeskim:mentionsumls-concept:C0029005lld:lifeskim
pubmed-article:8102189lifeskim:mentionsumls-concept:C0080032lld:lifeskim
pubmed-article:8102189lifeskim:mentionsumls-concept:C1704824lld:lifeskim
pubmed-article:8102189lifeskim:mentionsumls-concept:C1550594lld:lifeskim
pubmed-article:8102189lifeskim:mentionsumls-concept:C1548760lld:lifeskim
pubmed-article:8102189lifeskim:mentionsumls-concept:C1547300lld:lifeskim
pubmed-article:8102189lifeskim:mentionsumls-concept:C0580822lld:lifeskim
pubmed-article:8102189pubmed:issue6lld:pubmed
pubmed-article:8102189pubmed:dateCreated1993-9-7lld:pubmed
pubmed-article:8102189pubmed:abstractTextAn 83-year-old male was admitted with a right pleural effusion and generalized lymphadenopathy. Serum LDH level was elevated to 801 IU/L, and the pathological diagnosis from inguinal lymph node needle biopsy was malignant lymphoma (ML) of diffuse, large cell, non-cleaved type, according to the working formulation. The surface phenotypes of the malignant cells from the pleural effusion were analyzed by a fluorescent-activated cell sorter with a panel of monoclonal antibodies (MAbs). The ML cells coexpressed antigens detected by MAbs CD10 (CALLA), CD19, CD20, CD22, CD24, CD38, Ia, c-neu and surface immunoglobulin G kappa. A high expression of NRAS p21 was also detected by cytoplasmic immunofluorescence technique. The patient died 19 days later despite a combination of chemotherapy and intensive supportive therapy. From these findings it seems that c-neu may be a prognostic indicator not only for breast cancers but also for lymphoproliferative disorders. Further accumulation of such cases is needed.lld:pubmed
pubmed-article:8102189pubmed:languagejpnlld:pubmed
pubmed-article:8102189pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8102189pubmed:citationSubsetIMlld:pubmed
pubmed-article:8102189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8102189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8102189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8102189pubmed:statusMEDLINElld:pubmed
pubmed-article:8102189pubmed:monthJunlld:pubmed
pubmed-article:8102189pubmed:issn0301-1542lld:pubmed
pubmed-article:8102189pubmed:authorpubmed-author:MiyazawaTTlld:pubmed
pubmed-article:8102189pubmed:authorpubmed-author:KurataTTlld:pubmed
pubmed-article:8102189pubmed:authorpubmed-author:ImamuraNNlld:pubmed
pubmed-article:8102189pubmed:authorpubmed-author:FurukawaNNlld:pubmed
pubmed-article:8102189pubmed:authorpubmed-author:DoiMMlld:pubmed
pubmed-article:8102189pubmed:authorpubmed-author:MineshitaMMlld:pubmed
pubmed-article:8102189pubmed:issnTypePrintlld:pubmed
pubmed-article:8102189pubmed:volume31lld:pubmed
pubmed-article:8102189pubmed:ownerNLMlld:pubmed
pubmed-article:8102189pubmed:authorsCompleteYlld:pubmed
pubmed-article:8102189pubmed:pagination744-8lld:pubmed
pubmed-article:8102189pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:meshHeadingpubmed-meshheading:8102189-...lld:pubmed
pubmed-article:8102189pubmed:year1993lld:pubmed
pubmed-article:8102189pubmed:articleTitle[Aggressive diffuse lymphoma with malignant pleural effusion expressing c-erbB-2 (neu) oncogene products].lld:pubmed
pubmed-article:8102189pubmed:affiliationDepartment of Respiratory Medicine, Hiroshima City Hospital, Japan.lld:pubmed
pubmed-article:8102189pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8102189pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:8102189pubmed:publicationTypeCase Reportslld:pubmed